Harvard Bioscience, Inc. (HBIO) Financials
HBIO Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 137.4 million | 64.3 million |
2023-09-30 | 139.7 million | 65.4 million |
2023-06-30 | 142.9 million | 67.5 million |
2023-03-31 | 145.6 million | 71.2 million |
HBIO Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | 3.2 million | 1.4 million |
2023-09-30 | 4.0 million | 1.4 million |
2023-06-30 | 2.9 million | 1.1 million |
2023-03-31 | 1.6 million | 1.2 million |
HBIO Net Income
No data available :(
HBIO Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 4.3 million | - | 6.2 million |
2023-09-30 | 5.3 million | - | 6.5 million |
2023-06-30 | 4.3 million | 38.2 million | 6.8 million |
2023-03-31 | 3.8 million | - | 7.1 million |
HBIO Shares Outstanding
HBIO Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 1.1 million | 3.2 million | 5.3 million | 6.2 million |
2023-09-30 | 401000 | 2.8 million | 5.8 million | 5.7 million |
2023-06-30 | 625000 | 3.0 million | 5.4 million | 6.2 million |
2023-03-31 | 224000 | 2.9 million | 6.3 million | 6.0 million |
HBIO Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 28.2 million | 13.2 million |
2023-09-30 | 25.4 million | 10.6 million |
2023-06-30 | 28.8 million | 12.1 million |
2023-03-31 | 30.0 million | 11.6 million |
HBIO
Price: $3.85
52 week price:
Earnings Per Share: -0.08 USD
P/E Ratio: -59.13
Exchange: NGM
Sector: Healthcare
Industry: Medical Instruments & Supplies
Volume: 13674
Ebitda: 836000Market Capitalization: 167.2 million